Pacific Biosciences Of California (PACB) Acquisitions (2021)
Pacific Biosciences Of California (PACB) posted quarterly Acquisitions of $291.2 million for Q4 2021.
Pacific Biosciences Of California (PACB) Acquisitions (2021) Analysis & Trends
Pacific Biosciences Of California's Acquisitions history runs 1 years deep, the most recent figure standing at $291.2 million for Q4 2021.
- In Q4 2021, Acquisitions changed N/A year-over-year to $291.2 million; the TTM figure through Dec 2024 stood at $291.2 million (changed N/A YoY), while the FY2023 annual figure was $102000.0, changed N/A from the prior year.
- Acquisitions for Q4 2021 stood at $291.2 million.
- The five-year high for Acquisitions was $291.2 million in Q4 2021, with the low at $291.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 291.23 Mn |